Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Steiner

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2014
Dual implantable electronic device therapySebastian Reif, Philipp Steiner, Ellen Hoffmann
Cancer Biology & Therapy|December 23, 2003
Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cellsJian Yu, Sagarika Tiwari, Philipp Steiner, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imagingDavid Surguladze, Philipp Steiner, Marie Prewett, et al.
Anticancer Research|May 25, 2004
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?Rupert Prommegger, Christian Ensinger, Philipp Steiner, et al.
Water Research|June 1, 2023
Predicting microbial water quality in on-site water reuse systems with online sensorsEva Reynaert, Philipp Steiner, Qixing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptorPhilipp Steiner, Christopher Joynes, Rajiv Bassi, et al.
Cancer Research|July 19, 2005
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implicationsYolanda Fernández, Monique Verhaegen, Thomas P Miller, et al.
Cancer Research|January 20, 2007
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growthPirjo Laakkonen, Marika Waltari, Tanja Holopainen, et al.
Anticancer Research|June 17, 2009
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer modelsJames R Tonra, Erik Corcoran, Dhanvanthri S Deevi, et al.
Molecular Cancer Therapeutics|October 5, 2007
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non small cell lung cancersJacqueline F Doody, Ying Wang, Sheetal N Patel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2014
Dual implantable electronic device therapySebastian Reif, Philipp Steiner, Ellen Hoffmann
Cancer Biology & Therapy|December 23, 2003
Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cellsJian Yu, Sagarika Tiwari, Philipp Steiner, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imagingDavid Surguladze, Philipp Steiner, Marie Prewett, et al.
Anticancer Research|May 25, 2004
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?Rupert Prommegger, Christian Ensinger, Philipp Steiner, et al.
Water Research|June 1, 2023
Predicting microbial water quality in on-site water reuse systems with online sensorsEva Reynaert, Philipp Steiner, Qixing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptorPhilipp Steiner, Christopher Joynes, Rajiv Bassi, et al.
Cancer Research|July 19, 2005
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implicationsYolanda Fernández, Monique Verhaegen, Thomas P Miller, et al.
Cancer Research|January 20, 2007
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growthPirjo Laakkonen, Marika Waltari, Tanja Holopainen, et al.
Anticancer Research|June 17, 2009
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer modelsJames R Tonra, Erik Corcoran, Dhanvanthri S Deevi, et al.
Molecular Cancer Therapeutics|October 5, 2007
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non small cell lung cancersJacqueline F Doody, Ying Wang, Sheetal N Patel, et al.
Pageof 2